Beta gamma counters

InformationHS-1371 HS-1371 is a potent RIP3 kinase inhibitor with an IC50 of 20.8 nM. It binds to the ATP binding pocket of RIP3 and inhibits ATP binding to prevent RIP3 enzymatic activity in vitro.TargetsRIP3 kinase 20.8 nMIn vitroHS-1371 shows an

GSK1838705A is a potent IGF-1R inhibitor with IC50 of 2.0 nM, modestly potent to IR and ALK with IC50 of 1.6 nM and 0.5 nM, respectively, and little activity to other protein kinases.An ATP-competitive inhibitor of IGF-IR, IR, and ALK in various

GSK1838705A is a potent IGF-1R inhibitor with IC50 of 2.0 nM, modestly potent to IR and ALK with IC50 of 1.6 nM and 0.5 nM, respectively, and little activity to other protein kinases.An ATP-competitive inhibitor of IGF-IR, IR, and ALK in various

GSK1838705A is a potent IGF-1R inhibitor with IC50 of 2.0 nM, modestly potent to IR and ALK with IC50 of 1.6 nM and 0.5 nM, respectively, and little activity to other protein kinases.An ATP-competitive inhibitor of IGF-IR, IR, and ALK in various

GSK1838705A is a potent IGF-1R inhibitor with IC50 of 2.0 nM, modestly potent to IR and ALK with IC50 of 1.6 nM and 0.5 nM, respectively, and little activity to other protein kinases.An ATP-competitive inhibitor of IGF-IR, IR, and ALK in various

GSK1838705A is a potent IGF-1R inhibitor with IC50 of 2.0 nM, modestly potent to IR and ALK with IC50 of 1.6 nM and 0.5 nM, respectively, and little activity to other protein kinases.An ATP-competitive inhibitor of IGF-IR, IR, and ALK in various

Benzodiazepine inverse agonist.

Benzodiazepine inverse agonist.

Benzodiazepine inverse agonist.

Benzodiazepine inverse agonist.

E-3810.

High affinity, potent and selective Hsp90 inhibitor.